cannabis industry Related News
NOBL Group: a global leader in cannabis data & media
NOBL has assembled a leadership team of industry pioneers, innovators and experts combined with key leaders from dynamic fields, unlocking opportunities in the world...
Symtomax: the medical cannabis company leading the field
Discover how the Porto based medical cannabis company, Symtomax, is poised to conquer the European market and beyond.
Symtomax based in Porto, Portugal are licenced...
EMMAC Life Sciences and its successful issue of Convertible Loan Notes
EMMAC Life Sciences Group, Europe’s leading independent cannabis company, is pleased to announce it has raised £15 million via an issue of Convertible Loan...
The pre-licence for cultivating medical cannabis in Portugal
The Portuguese team of Cannexpor Pharma now possess the legal right for cultivating medical cannabis in Portugal.
We are delighted to announce that the Portuguese...
Limiting illicit cannabis trade as the industry continues expanding
Most regions around the world allow young adults at the age of 18 to enjoy or purchase their own alcohol and tobacco.
However, the US...
Cannabis E-commerce is becoming a viable platform for the industry
As more consumers begin using cannabis products, cannabis e-commerce is becoming a more viable option for the industry.
Over the past several decades, the retail...
Europe could lose more ground in the medicinal cannabis industry
Europe is at risk of losing the market share to Africa in the medicinal cannabis industry, and Eco Equity have spotted the global potential.
There...
Denmark attracts major Canadian cannabis investments
Nine months ago, the Danish pharma specialist NNE sowed a seed – a team providing strategic business consulting on growing, producing and distributing medical...
Sustainable future for cannabis: why Europe should prefer SmallCannabis™
Global cannabis prohibition is ending, and supply of legal cannabis is increasing. Here, Jim Plamondon of Thai Cannabis talks more about the sustainable future...
Zelda merger creates leading therapeutic medical cannabis company
Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and...
Australian Government invests $3m for medical cannabis research
The Australian Government is investing AUD $3m (~€1.65m) from the Medical Research Future Fund (MRFF) into medical cannabis research.
The research is intended to examine...
European portfolio launched to improve patient access to medical cannabis
LYPHE GROUP launches today, bringing together a portfolio of leading companies in the medical cannabis industry to transform access to cannabis-based medical products for...
Treatment of pain and inflammation with Tetra Bio-Pharma’s CAUMZ kit
CAUMZ is a non-opioid alternative in Phase 3 development for the treatment of pain and inflammation, and Tetra are one step closer to bringing...
Perception shift helps to propel cannabis industry to new heights
The cannabis market has shown investors its long-term potential in recent years.
Despite legal setbacks on the federal level, the young cannabis industry has made impressive...
Cannabis camp will provide cultivation and extraction capabilities
Ikänik Farms is pleased to announce it has received all necessary licenses required to begin construction of its cannabis camp in Adelanto, California.
Ikänik Farms...
New Frontier Data releases new 2019 US hemp study
New Frontier Data, the authority in data, analytics and business intelligence for the global cannabis industry, in collaboration with Vote Hemp, releases The US...
The Federal Government of Brazil is facilitating the importation of medicinal CBD
A new system tool was announced by the Federal Government to facilitate the importation of medicinal CBD in Brazil, and CBD Vida will be...
Colombia the land of opportunity: cannabis licences for sale
Did you know Blue Dream Industries, the cannabis consulting company, has multiple cannabis licences for sale? Could this be the perfect way to connect...
Altitude Investment Management invests $5.5 Million in KannaSwiss
Altitude Investment Management announced today a $5.5 (~€5m) million investment in Switzerland-based KannaSwiss as its first European investment.
Earlier this year, Altitude Investment Management plc (AIM plc),...
CannaBiz Innovation Hub 2019: innovation and scale with cannabis
Leading organisations in the cannabis industry will be discussing cannabis products, the supply chain, quality control, marketing, distribution and more at Cannabis Innovation Hub...